Whole Genome Amplification (WGA) offers vast opportunities in personalized medicine, cancer research, and reproductive health by enabling DNA analysis from minimal samples. Technological advancements ...
Thermo Fisher Scientific has introduced the Applied Biosystems™ SwiftArrayStudio™ Microarray Analyzer, designed for fast and scalable sample analysis. In conjunction with two new arrays – the Applied ...
NEW YORK – Thermo Fisher Scientific, Genovation Health, and XYGene have signed a multiyear comarketing collaboration agreement aimed at expanding access to integrated genomic solutions, the firms ...
This narrative review reports recent advances in transfusion medicine, encompassing enhancements in molecular diagnostics, blood engineering, and therapeutic technologies. It summarizes findings from ...
Join us for an insightful webinar on the use of polygenic risk scores (PRS) for cardiovascular disease (CVD). The analysis of genetic variation across large populations plays a crucial role in ...
SOUTH SAN FRANCISCO, Calif. & ANN ARBOR, Mich.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health ...
As per precedence Research, the global DNA microarray market size is projected to grow approximately USD 6.13 billion by 2034 from valued at USD 2.28 billion in 2023. It is expanding at a CAGR of 9.4% ...
Across a multitude of genomic assays, scientists begin with sample collection. Whether their analyte is destined for genotyping, microarrays, or high throughput sequencing, researchers can benefit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback